Anthony Melendez

We serve the people and organizations that transform human health.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Raised $313,000,000.00 from F-Prime Capital, Janus Henderson Investors, PremjiInvest, Piper Heartland Healthcare Capital, Bioqube Ventures, Omega Funds, The Rise Fund, Braidwell, RA Capital Management and Eight Roads Ventures.

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

Raised $41,000,000.00 from CureDuchenne Ventures, OrbiMed, Logos Capital and Surveyor Capital.

Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.

Raised $359,500,000.00 from Cowen Healthcare Investments, Deep Track Capital, Affinity Asset Advisors, Braidwell, StemPoint Capital, Logos Capital, Paradigm BioCapital Advisors, Acuta Capital Partners, TCG Crossover and Qiming Venture Partners USA.

AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.

Raised $15,000,249,999.00.

Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

Raised $140,699,993.00 from Longitude Capital, WS Investment Company, Avidity Partners, GC&H Investments, Sofinnova Investments, Biotechnology Value Fund, Vida Ventures, AbbVie and Surveyor Capital.

Sustainable Private Equity and Credit Investments

BCG Securities focuses on wealth management with high net worth individuals.